more emphasis on reducing "trans fats" in foods
You'll see more emphasis on reducing "trans fats" in foods.
In fact, FDA will require labels to spell out the amount of trans fats in foods by 2006.
Trans fats are at least as harmful as saturated fats.
Table of Contents
- The FDA will soon approve the new "super statin" Crestor (rosuvastatin)
- whether they should take finasteride (Proscar) to PREVENT prostate cancer
- broader selection of testosterone products
- Pravigard PAC, the first statin and aspirin combo
- whether Coreg is more effective than metoprolol for heart failure
- whether Lantus needs to be discarded after 28 days
- Two new HIV drugs, Emtriva and Reyataz
- more emphasis on reducing "trans fats" in foods
- drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate)
- potential interaction between Evista (raloxifene) and levothyroxine (Synthroid, etc)
- which levothyroxine products can be substituted for each other
- about promoting Neurontin for off-label uses
- Stalevo, a combo product for Parkinson's disease
- Patients with peanut allergy are hearing that they should keep a bottle of activated charcoal on hand
- the risk of breast cancer in women taking hormone therapy
- concerns about the safety of black cohosh
- Medicare reimbursement for giving flu shots has almost doubled